iDD-003

N/A

Report date: 2025/02/01 20:00:06

Base Information

Drug NameiDD-003

Drug Alias Nameanti-CD5 mAb (iDD biotech)MR-007

ClassificationBiologics > Protein drugs > Immunoglobulin > Antibody > Monoclonal antibody > Monoclonal antibody humanizedBiologics > Protein drugs > Immunoglobulin > Antibody > Monoclonal antibody > Monoclonal antibody murine

Mechanisms of ActionT-cell surface glycoprotein CD5 inhibitors

TargetsT-cell surface glycoprotein CD5

Therapy Area/IndicationsAutoimmune DiseasesNeoplasms

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryFrance

CombinationsNo

Global Highest StatusPending (Preclinical)

Highest Status in ChinaN/A

Originator CompaniesIdd Biotech

China Registration ClassN/A

Develop Information

Active CompaniesN/A

Inactive CompaniesIdd Biotech

Active IndicationsN/A

Inactive IndicationsAutoimmune DiseasesNeoplasms

Other Information

ATC CodeN/A